Med School: Separating Hype from Hope in Genome Science

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all.
(Underwritten by America's Biopharmaceutical Companies)

Speakers: Robert C. Green
Festival: Spotlight Health 2018

Watch and Listen: Health

Invalid health news comes in many flavors. Some is utterly fake and potentially dangerous: asserting links between... See more
US Senator Mitch McConnell has just announced that he will bring health reform legislation to the Senate floor for a... See more
Dip into a groundbreaking medical memoir by Kurt Newman, president and CEO of Children’s National Medical Center and... See more
The genius of artificial intelligence (AI) is its capacity to swiftly mine repositories of data, such as the vast... See more
Who are you? That question has become ever more complicated over the last decade of scientific discovery. Our genomes... See more
Whether they remain free of diagnosable disease or become afflicted by dementia, our brains inevitably change as we... See more

Pages